VTGN icon

VistaGen Therapeutics
VTGN

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $7.45M invested in VistaGen Therapeutics in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.04M
2
+$126K
3
+$125K
4
Goldman Sachs
Goldman Sachs
New York
+$51K
5
LTFS
Ladenburg Thalmann Financial Services
Florida
+$8.9K

Top Sellers

1
-$1.14M
2
-$183K
3
-$8.88K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.26M
2
$1.49M
3
$1.45M
4
$1.24M
5
$575K
6
$126K
7
$125K
8
$86K
9
$51K
10
$40K
11
$5K
12
$3K
13
–